☰

Raymond E. Lenhard - Publications

Affiliations: 
Orthopaedics Johns Hopkins University, Baltimore, MD 
Tree Info Grants Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
1999 Oken MM, Leong T, Lenhard RE, Greipp PR, Kay NE, Van Ness B, Keimowitz RM, Kyle RA. The addition of interferon or high dose cyclophosphamide to standard chemotherapy in the treatment of patients with multiple myeloma: phase III Eastern Cooperative Oncology Group Clinical Trial EST 9486. Cancer. 86: 957-68. PMID 10491521 DOI: 10.1002/(SICI)1097-0142(19990915)86:6<957::AID-CNCR10>3.0.CO;2-8  0.35
1994 Lenhard RE, Kalish LA, Oken MM, Ettinger DS, Glick J. Timed-sequential high-dose cyclophosphamide and vincristine in the treatment of multiple myeloma. Cancer. 73: 2113-8. PMID 8156516 DOI: 10.1002/1097-0142(19940415)73:8<2113::Aid-Cncr2820730816>3.0.Co;2-3  0.384
1994 Lenhard RE, Daniels MJ, Oken MM, Glick JH, Ettinger DS, Kalish L, O'Connell MJ. An aggressive high dose cyclophosphamide and prednisone regimen for advanced multiple myeloma. Leukemia & Lymphoma. 13: 485-9. PMID 8069193 DOI: 10.3109/10428199409049639  0.404
1993 Lenhard RE. A large private university hospital system. The Johns Hopkins Oncology Center. Cancer. 72: 2820-3. PMID 8402511 DOI: 10.1002/1097-0142(19931101)72:9+<2820::Aid-Cncr2820721509>3.0.Co;2-C  0.366
1987 Lenhard RE, Enterline JP, Crowley J, Ho GY. The effects of distance from primary treatment centers on survival among patients with multiple myeloma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 5: 1640-5. PMID 3655862 DOI: 10.1200/Jco.1987.5.10.1640  0.425
1987 Oken MM, Lenhard RE, Tsiatis AA, Glick JH, Silverstein MN. Contribution of prednisone to the effectiveness of hexamethylmelamine in multiple myeloma. Cancer Treatment Reports. 71: 807-11. PMID 3113729  0.32
1985 Lenhard RE, Order SE, Spunberg JJ, Asbell SO, Leibel SA. Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 3: 1296-300. PMID 4045523 DOI: 10.1200/Jco.1985.3.10.1296  0.405
1984 Lenhard RE, Oken MM, Barnes JM, Humphrey RL, Glick JH, Silverstein MN. High-dose cyclophosphamide. An effective treatment for advanced refractory multiple myeloma. Cancer. 53: 1456-60. PMID 6697291 DOI: 10.1002/1097-0142(19840401)53:7<1456::Aid-Cncr2820530705>3.0.Co;2-C  0.444
1984 Lenhard RE, Blum BI. Practical applications of OCIS, a clinical information system for oncology. Computers in Biology and Medicine. 14: 15-23. PMID 6370578 DOI: 10.1016/0010-4825(84)90016-7  0.323
1983 Rostock RA, Siegelman SS, Lenhard RE, Wharam MD, Order SE. Thoracic CT scanning for mediastinal Hodgkin's disease: Results and therapeutic implications International Journal of Radiation Oncology, Biology, Physics. 9: 1451-1457. PMID 6629888 DOI: 10.1016/0360-3016(83)90317-6  0.331
1983 Oken MM, Costello WG, Johnson GJ, Lenhard RE, Ezdinli EZ, Orlow E, Barnes JM, Berard CW, Glick JH. The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimen. Cancer. 51: 1581-6. PMID 6339028 DOI: 10.1002/1097-0142(19830501)51:9<1581::Aid-Cncr2820510905>3.0.Co;2-L  0.443
1983 Woo KB, Waalkes TP, Abeloff MD, Lenhard RE, Gehrke CW, Kuo KC. Urinary polyamines for evaluating the course of disease for patients with small cell carcinoma of the lung. Cancer. 52: 1684-90. PMID 6311401 DOI: 10.1002/1097-0142(19831101)52:9<1684::Aid-Cncr2820520923>3.0.Co;2-K  0.348
1982 Rostock RA, Giangreco A, Wharam MD, Lenhard R, Siegelman SS, Order SE. CT scan modification in the treatment of mediastinal Hodgkin's disease Cancer. 49: 2267-2275. PMID 7074542 DOI: 10.1002/1097-0142(19820601)49:11<2267::Aid-Cncr2820491111>3.0.Co;2-S  0.407
1982 Laszlo J, Lenhard R, Dahlberg S, Feigl P. A profile of treatment approaches used at comprehensive cancer centers Journal of Chronic Diseases. 35: 853-859. PMID 6292252 DOI: 10.1016/0021-9681(82)90050-9  0.376
1980 Ezdinli EZ, Costello WG, Icli F, Lenhard RE, Johnson GJ, Silverstein M, Berard CW, Bennett JM, Carbone PP. Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology Group. Cancer. 45: 261-7. PMID 6985832 DOI: 10.1002/1097-0142(19800115)45:2<261::Aid-Cncr2820450210>3.0.Co;2-W  0.383
1980 Rostock R, Giangreco A, Wharam MD, Lenhard R, Siegelman S, Order S. Control and cat scan modification of the treatment of mediastinal Hodgkin's disease International Journal of Radiation Oncology Biology Physics. 6: 1397. DOI: 10.1016/0360-3016(80)90498-8  0.303
1979 Ezdinli EZ, Costello W, Wasser LP, Lenhard RE, Berard CW, Hartsock R, Bennett JM, Carbone PP. Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomas. Cancer. 43: 544-50. PMID 369677 DOI: 10.1002/1097-0142(197902)43:2<544::Aid-Cncr2820430221>3.0.Co;2-P  0.348
1979 Abeloff MD, Ettinger DS, Khouri NF, Lenhard RE. Intensive induction therapy for small cell carcinoma of the lung Cancer Treatment Reports. 63: 519-524. PMID 221117  0.3
1978 Ezdinli EZ, Costello W, Lenhard RE, Bakemeier R, Bennett JM, Berard CW, Carbone PP. Survival of nodular versus diffuse pattern lymphocytic poorly differentiated lymphoma. Cancer. 41: 1900-6. PMID 580597 DOI: 10.1002/1097-0142(197805)41:5<1990::Aid-Cncr2820410545>3.0.Co;2-G  0.378
1978 Lenhard RE, Ezdinli EZ, Costello W, Bennett JM, Horton J, Amorisi EL, Stolbach L, Wolter J. Treatment of histiocytic and mixed lymphomas: a comparison of two, three and four drug chemotherapy. Cancer. 42: 41-52. PMID 352507 DOI: 10.1002/1097-0142(197807)42:1<41::Aid-Cncr2820420107>3.0.Co;2-D  0.412
1976 Ezdinli E, Pocock S, Berard CW, Aungst CW, Silverstein M, Horton J, Bennett J, Bakemeier R, Stolbach L, Perlia C, Brunk SF, Lenhard RE, Klaassen DJ, Richter P, Carbone P. Comparison of intensive versus moderate chemotherapy of lymphocytic lymphomas: a progress report. Cancer. 38: 1060-8. PMID 989030 DOI: 10.1002/1097-0142(197609)38:3<1060::Aid-Cncr2820380304>3.0.Co;2-V  0.422
1976 Lenhard RE, Prentice RL, Owens AH, Bakemeier R, Horton JH, Shnider BI, Stolbach L, Berard CW, Carbone PP. Combination chemotherapy of the malignant lymphomas: a controlled clinical trial. Cancer. 38: 1052-9. PMID 782685 DOI: 10.1002/1097-0142(197609)38:3<1052::Aid-Cncr2820380303>3.0.Co;2-T  0.45
1975 Lenhard RE, Densen P, Lenhard RE. Salmonella empyema and Hodgkin's disease. Southern Medical Journal. 68: 363-6. PMID 1091004 DOI: 10.1097/00007611-197503000-00023  0.326
1973 Lenhard RE. Eastern cooperative oncology group studies. Archives of Internal Medicine. 131: 418-20. PMID 4688039 DOI: 10.1001/Archinte.1973.00320090108012  0.396
1972 Costanza ME, Nathanson L, Lenhard R, Wolter J, Colsky J, Oberfield RA, Schilling A. Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosourea. Cancer. 30: 1457-61. PMID 4641757 DOI: 10.1002/1097-0142(197212)30:6<1457::Aid-Cncr2820300607>3.0.Co;2-5  0.389
1969 Hoogstraten B, Owens AH, Lenhard RE, Glidewell OJ, Leone LA, Olson KB, Harley JB, Townsend SR, Miller S, Spurr CL. Combination chemotherapy in lymphosarcoma and reticulum cell sarcoma. Blood. 33: 370-8. PMID 4886120 DOI: 10.1182/Blood.V33.2.370.370  0.395
1950 LENHARD RE. Prognosis in poliomyelitis. The Journal of Bone and Joint Surgery. American Volume. 32: 71-9. PMID 15401723 DOI: 10.2106/00004623-195032010-00006  0.319
Show low-probability matches.